Rankings
▼
Calendar
TKNO FY 2024 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$133M
FY 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$38M
+2.9% YoY
Gross Profit
$7M
19.2% margin
Operating Income
-$26M
-69.3% margin
Net Income
-$27M
-70.9% margin
EPS (Diluted)
$-0.57
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$14M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$119M
Total Liabilities
$36M
Stockholders' Equity
$82M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$38M
$37M
+2.9%
Gross Profit
$7M
$10M
-29.8%
Operating Income
-$26M
-$36M
+26.5%
Net Income
-$27M
-$37M
+27.3%
← Q4 2023
All Quarters
Q1 2024 →